Methylcobalamin
MeCbl has promising mechanisms and positive preclinical data from two different ALS models. Unfortunately, the anecdotal data we found did not identify any clear specific benefit, and the best of…
Trial: A
Two or more peer-reviewed publications describing benefits in well-designed randomized, blinded placebo-controlled phase III trials